Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2746240 | 1.00 | CNR2 (0.60) | CNR2CNR1 | |
| SCHEMBL2746791 | 0.91 | CNR2 (0.65) | CNR2CNR1 | |
| SCHEMBL5524509 | 0.91 | CNR2 (0.65) | CNR2CNR1 | |
| SCHEMBL5517040 | 0.89 | CNR2 (0.63) | CNR2CNR1 | |
| SCHEMBL2746394 | 0.89 | CNR2 (0.63) | CNR2CNR1 | |
| SCHEMBL2746493 | 0.87 | CNR1 (0.70) | CNR2CNR1 | |
| SCHEMBL5522103 | 0.84 | CNR2 (0.76) | CNR2CNR1 | |
| SCHEMBL2745548 | 0.83 | CNR2 (0.76) | CNR2CNR1 | |
| SCHEMBL2746350 | 0.81 | CNR2 (0.76) | CNR2CNR1 | |
| SCHEMBL5522109 | 0.81 | CNR2 (0.75) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8178681-B2 | methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency | SHIONOGI & CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178681-B2 | methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency | SHIONOGI & CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |